Impact of regular enteral feeding via jejunostomy during neo-adjuvant chemotherapy on body composition in patients with oesophageal cancer

doi:10.4251/wjgo.v11.i12.1182

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4294)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

246

WORD

192

HTML

2000

Figures (1-4)

225

Tables (1-4)

167

Sum=2830

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

565

Download

899

Sum=1464

Dec 15, 2019 (publication date) through May 14, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastrointest Oncol. Dec 15, 2019; 11(12): 1182-1192
Published online Dec 15, 2019. doi: 10.4251/wjgo.v11.i12.1182

Full Size Figure Download Figure

Figure 1 Radiologic image showing a comparison of body composition at diagnosis (A) and post neo-adjuvant (B) chemotherapy (two computed tomography scans of the third lumbar vertebra skeletal mass) for the same patient. Red: Muscle; Yellow: Visceral fat; Blue: Subcutaneous fat.

Citation: Mohamed IM, Whiting J, Tan BH. Impact of regular enteral feeding via jejunostomy during neo-adjuvant chemotherapy on body composition in patients with oesophageal cancer. World J Gastrointest Oncol 2019; 11(12): 1182-1192
URL: https://www.wjgnet.com/1948-5204/full/v11/i12/1182.htm
DOI: https://dx.doi.org/10.4251/wjgo.v11.i12.1182